Pitavastatin received FDA approval on [1].
When did the FDA approve Pitavastatin?
The U.S. Food and Drug Administration (FDA) approved pitavastatin on [1].
What is Pitavastatin used for?
Pitavastatin is a statin medication used to lower cholesterol levels. Specifically, it is prescribed to reduce elevated levels of low-density lipoprotein (LDL) cholesterol, total cholesterol, triglycerides, and apolipoprotein B in adults with primary hyperlipidemia or mixed dyslipidemia [2]. It also helps to increase high-density lipoprotein (HDL) cholesterol levels [2]. Pitavastatin is indicated as an adjunctive therapy to diet when the response to a restricted diet alone has not been adequate [2].
How does Pitavastatin work?
Pitavastatin works by inhibiting the enzyme HMG-CoA reductase [3]. This enzyme plays a crucial role in the liver's production of cholesterol [3]. By blocking HMG-CoA reductase, pitavastatin reduces the synthesis of cholesterol, leading to lower levels of LDL cholesterol in the blood [3].
What are the brand names for Pitavastatin?
Pitavastatin is marketed under the brand name Livalo [4].
When does the patent for Pitavastatin expire?
Information on specific patent expiry dates for pitavastatin can be found on DrugPatentWatch.com [5]. Patent expirations are crucial for the potential introduction of generic versions of the drug [5].
How does Pitavastatin compare to other statins?
Pitavastatin is a member of the statin class of drugs, which includes others like atorvastatin, simvastatin, and rosuvastatin. While all statins work by lowering cholesterol, they can differ in their potency, metabolic pathways, and potential side effect profiles. Clinical studies have compared pitavastatin to other statins, with results often showing comparable efficacy in lowering LDL cholesterol [6].
What are the common side effects of Pitavastatin?
Common side effects associated with pitavastatin use include muscle pain (myalgia), joint pain (arthralgia), and diarrhea [2]. However, not everyone experiences these side effects.
Can generic versions of Pitavastatin be made?
The ability to manufacture generic versions of pitavastatin is dependent on patent status and regulatory approvals. Once patents expire and if there are no other market exclusivities, generic manufacturers can seek FDA approval to market their versions of the drug [5].
How is Pitavastatin prescribed?
Pitavastatin is typically prescribed as a once-daily oral tablet. The usual starting dose is 2 mg, with the dose adjusted based on the patient's response and tolerance [2]. The maximum recommended dose is 4 mg per day [2].
Sources:
1. [FDA Approval Date of Pitavastatin]
2. [Pitavastatin Prescribing Information]
3. [Mechanism of Action of Statins]
4. [Brand Name of Pitavastatin]
5. [DrugPatentWatch.com]
6. [Comparative Efficacy of Statins]